Roche Diagnostics has announced that the Elecsys anti-hepatitis C virus (HCV) assay has received regulatory approval in Europe for the E170 analyser for modular analytics and the e601 module for the Cobas 6000 platform. The Elecsys anti-HCV assay is already available on the Elecsys 2010 and the Cobas e411 instruments.
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
10 Union Street, London, SE1 1SZ
2 March, 2026
Online
3-4 March, 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026
Online
10-11 March, 2026
Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026
